Genentech Rx For Global Pricing: Refuse To Sell Unless Price Is “Reasonable”
Executive Summary
Pharmaceutical companies should not market products in countries that do not allow "reasonable" prices for drugs, Genentech CEO Arthur Levinson declared during a March 12 investor conference